AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Cash Flow from Financing Activities | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of AARTI PHARMALABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹9.72 Cr |
Mar2023 | ₹-163 Cr |
Mar2022 | ₹260 Cr |
Mar2021 | - |
How is Cash Flow from Financing Activities of AARTI PHARMALABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹9.72 Cr | Positive | |
Mar2023 | ₹-163 Cr | Negative | |
Mar2022 | ₹260 Cr | 0 | |
Mar2021 | - | - |
Compare Cash Flow from Financing Activities of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹6,507.8 Cr | 12.7% | 10.1% | 44.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 12.7% |
10.1% |
44.6% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses